A cluster-randomized trial of enhanced labor ward-based PMTCT services to increase nevirapine coverage in Lusaka, Zambia
- 28 January 2010
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 24 (3) , 447-455
- https://doi.org/10.1097/qad.0b013e328334b285
Abstract
Determine whether enhanced labor ward-based services for prevention of mother-to-child transmission of HIV (PMTCT) would improve nevirapine (NVP) coverage. Cluster-randomized trial at 12 public-sector delivery centers in Lusaka, Zambia. Following a baseline surveillance period, 12 labor wards were randomized, six to offer opt-in HIV testing to women of unknown serostatus (with NVP administration as indicated) and to assess NVP adherence among known HIV-infected women. The six control labor wards provided the standard of care. The NVP coverage endpoint was defined as the proportion of HIV-infected/exposed women/infant pairs with confirmed NVP ingestion. We used generalized estimating equations (GEE) to determine the odds of coverage associated with the intervention and ultimately used the parameters for the estimated GEE model to estimate relative risk. Between October 2005 and January 2006, 7664 women gave birth at participating clinics. We collected anonymous-linked blood from 7592 (99%) umbilical cords; tested 7438 (97%) for HIV, 1618 (22%) were seropositive, and of these, 1279 (79%) were tested for NVP. At baseline (preintervention), the probability of HIV-infected/exposed women/infant pairs receiving NVP in treatment clinics (42%) was 0.89 times the probability of being covered in control clinics (53%) whereas during the intervention period the probability of treatment clinic coverage (52%) was 1.22 the probability control clinic coverage (43%), representing a multiplicative effect of 1.37 upon the RR at baseline (ratio of relative risks 1.37, bootstrapped 95% CI, 1.04–1.77). Labor ward-based PMTCT programs are feasible and can have a significant, positive impact on NVP coverage.Keywords
This publication has 24 references indexed in Scilit:
- Monitoring effectiveness of programmes to prevent mother-to-child HIV transmission in lower-income countriesPublished by WHO Press ,2008
- Monitoring and evaluation of programmes to prevent mother to child transmission of HIV in AfricaBMJ, 2007
- High acceptability of voluntary counselling and HIV‐testing but unacceptable loss to follow up in a prevention of mother‐to‐child HIV transmission programme in rural Malawi: scaling‐up requires a different way of actingTropical Medicine & International Health, 2005
- Effectiveness of a city-wide program to prevent mother-to-child HIV transmission in Lusaka, ZambiaAIDS, 2005
- Rapid testing strategies for HIV-1 serodiagnosis in high-prevalence African settingsAmerican Journal of Preventive Medicine, 2004
- Universal nevirapine upon presentation in labor to prevent mother-to-child HIV transmission in high prevalence settingsAIDS, 2004
- Prevention of mother-to-child transmission of HIV in Africa: successes and challenges in scaling-up a nevirapine-based program in Lusaka, ZambiaAIDS, 2003
- Mother-to-child HIV transmission in resource poor settingsAIDS, 2003
- High-performance liquid chromatographic assay to determine the plasma levels of HIV-protease inhibitors (amprenavir, indinavir, nelfinavir, ritonavir and saquinavir) and the non-nucleoside reverse transcriptase inhibitor (nevirapine) after liquid–liquid extractionJournal of Chromatography B: Biomedical Sciences and Applications, 2001
- Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trialThe Lancet, 1999